Skip to main content
Screener/Healthcare/Biotechnology

JANX — Janux Therapeutics, Inc.

NASDAQ
$17.36-0.47 (-2.66%)
Small CapUnder $20HealthcareHigh Beta
$12.12
$35.34
$17.13
$18.17
EPS (TTM)$-1.84
P/E Ratio-7.91
Dividend Yield—
Market Cap$1.06B
Volume290K
Prev Close$17.83
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$3.7M-$24.4M$-0.390.0%-652.6%
Q4 '25$7.9M-$31.9M$-0.51-13.5%-405.4%
Q3 '25$10.0M-$24.3M$-0.3995.0%-243.1%
Q2 '25$0-$33.9M$-0.55——
Q1 '25$0-$23.5M$-0.38——
Q4 '24$0-$20.2M$-0.36——
Q3 '24$439K-$28.1M$-0.51100.0%-6391.6%
Q2 '24$8.9M-$6.0M$-0.1194.3%-67.0%
Get Your Daily Market Recap